Search Results for

Showing 1 - 9 of 9 results
  1. Spotlight on members: Spark

    Spotlight on members From hospital funding to FDA approval Spark Therapeutics develops gene therapy for inherited retinal blindness After over two decades of research and development in gene therapy, Katherine A. High, MD, co-founder, president and chief scientific officer of Spark Therapeutics, is breathing a big sigh of relief this fall. On Oct. 12, the Food and Drug Administration unanimously voted to approve voretigene neparvovec, Spark Therapeutics' gene therapy treatment for inherited b

  2. Housing and registration

    Registration and housing Registration Rates shown in U.S. dollars   Early bird rate Advance rate Onsite rate   Through June 8  Through July 6      After July 6 Regular attendee $449 $495 $515 Student attendee*      $249 $295 $315  *Students are undergraduate and graduate students, post-graduate fellows, medical students, optometry students and residents. Registration includes: 2.5 days of programming Coffee breaks, two lunches, one opening reception Champalima

  3. Abstracts

    Abstracts Abstract submission is now closed. First authors were notified on April 20, 2018. For questions about abstracts, please send inquiries to: ooo@arvo.org or call 240.221.2900. Abstract reference tools Abstract Submission Policies and Procedures Abstract Submission FAQs Abstract Withdrawal and Substitute Presenter Policy Successful Abstract Submission Guidelines Commercial Relationship Disclosures Registering Clinical Trials Abstract Rejection Criteria

  4. Program

    Program Conference program The conference program includes podium sessions, with opening and closing keynote lectures, a tour of the Champalimaud Centre for the Unknown, poster sessions and multiple opportunities for attendees to network. Speakers are international experts in oncogenesis and oncology, from the Champalimaud Centre for the Unknown and other ophthalmic centers around the globe.  Program schedule overview Wednesday, July 18 – afternoon registration hours (Attendees may also chec

  5. Statement for the Use of Animals in Ophthalmic and Vision Research

    Statement for the Use of Animals in Ophthalmic and Vision Research Introduction Guidelines for the design of experiments Guidelines for the conduct of experiments Factors that relate specifically to the conduct of vision and ophthalmology experiments Investigators outside the United States Animal use guidelines Alternatives to animal research Animal use resources Organizations that promote proper and ethical use of laboratory animals Introduction Research in vision and ophthalmology i

  6. Registration

    NIH Updates for Human Subjects Research Administration

  7. Congressional briefing

    A Congressional briefing in Washington, D.C. highlighted how vision research pays for itself

  8. About

    Online event: May 22, 2018